Edesa Biotech, Inc.
EDSANASDAQHealthcareBiotechnology
As of Oct 23, 2026 close
- Market cap
- $24.95M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.72$20.32
- Volume (live)
- -
- Avg. volume (3M)
- 42.85K
Edesa Biotech (EDSA) Stock Price & Financial Analysis
Edesa Biotech Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $2.67 - $2.92 |
|---|---|
| 52-Week High | $20.32 |
| 52-Week Low | $0.72 |
| Open | $2.71 |
| Volume (last close) | 18.14K |
| Average Volume (3M) | 42.85K |
| 50-Day MA | $4.22 |
|---|---|
| 200-Day MA | $5.61 |
| 1-Year Change | +2.60% |
| Market Cap | 24.95M |
|---|---|
| Shares Outstanding | 9.01M |
| Price to Book (P/B) | 2.83 |
| EV/EBITDA | -1.00 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Edesa Biotech at a Glance
As of the Oct 23, 2026 close, Edesa Biotech (EDSA) has a market capitalization of $24.95M.
As of its latest reported balance sheet, it holds $10.33M in cash and securities against $0.00 of debt, a net cash position of $10.33M.
Edesa Biotech does not currently pay a dividend.
The share price is up 2.6% over the past year. At $2.77 (the Oct 23, 2026 close) it sits near the bottom of its 52-week range of $0.72 to $20.32, below its 200-day moving average of $5.61.
Frequently Asked Questions About Edesa Biotech
What is the current stock price for EDSA?
As of the Oct 23, 2026 close, EDSA stock trades at $2.77. The 52-week range is $0.72–$20.32, with a day range of $2.67–$2.92.
What is the P/E ratio for EDSA?
The P/E ratio (Price-to-Earnings) for EDSA is shown in the Key Statistics section. This valuation metric helps compare Edesa Biotech, Inc. to industry peers.
Does EDSA pay dividends?
Edesa Biotech does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for EDSA?
Analyst ratings and recommendations for EDSA are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of EDSA?
As of the Oct 23, 2026 close, Edesa Biotech's market capitalization is $25.0M, classifying it as a micro-cap company. Edesa Biotech operates in the Healthcare sector within the Biotechnology industry.